| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |